Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-74.99	8.00	31.99
Graham Fair Price	119.60	2395.31	1090.77
PEG	-99.99	< 0.005	148.00
Price/Book	8.71	0.56	0.52
Price/Cash Flow	inf	0.00	40.06
Prices/Earnings	-75.57	3.14	12.85
Price/Sales	-21.95	1.57	2.01
Price/FCF	inf	0.00	40.06
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	81.64	0.23	0.13
Operating Margin	298.14	0.17	0.04
ROA	359.07	0.03	< 0.005
ROE	0.01	0.04	344.99
ROIC	< 0.005	0.04	476.26
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.74	4.52	-83.57
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.18	4.81	2587.76
EPS QOQ	< 0.005	3.63	418186.75
FCF QOQ	0.06	-1.00	1515.17
Revenue QOQ	0.16	0.46	195.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21.76	6.26	-71.24
Days Sales Outstanding (DSO)	234.22	159.60	-31.86
Inventory Turnover	4.14	14.38	247.72
Debt/Capitalization	0.10	0.03	-63.87
Quick Ratio	2.13	2.34	10.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2294.12	2388.17	4.10
Cash	258.93	355.81	37.41
Capex	0.00	0.00	0.00
Free Cash Flow	29.58	0.00	inf
Revenue	590.78	856.56	44.99
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.33	2.44	4.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.89	-2.02	7.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating